| # | Filing Date | Period End Date | Type | Report Link | 
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating | 
|---|
 
																	 
																	Truist Securities analyst Asthika Goonewardene maintains IGM Biosciences (NASDAQ:IGMS) with a Hold and lowers the price targ...
 
																	IGM Biosciences (NASDAQ:IGMS) reported quarterly losses of $(0.50) per share which missed the analyst consensus estimate of $(0...
 
																	JP Morgan analyst Eric Joseph upgrades IGM Biosciences (NASDAQ:IGMS) from Underweight to Neutral.
 
																	
 
																	
 
																	
 
																	Jefferies analyst Roger Song downgrades IGM Biosciences (NASDAQ:IGMS) from Buy to Hold and lowers the price target from $48 ...
 
																	Truist Securities analyst Asthika Goonewardene maintains IGM Biosciences (NASDAQ:IGMS) with a Hold and lowers the price targ...